Figure 4.
Real-time polymerase chain reaction (RT-PCR) analysis of lncRNA expression and receiver operating characteristic (ROC) curves measuring the diagnostic efficiency of selected lncRNAs. (A) RT-PCR validation of the relative expression levels of lncRNA-C14orf64. (B) Relative expression levels of lncRNA-AC136007.2. (C) ROC curve for discriminating patients with AIS from healthy controls by lncRNA-C14orf64 had an area under curve (AUC) of 0.74 (95% CI, 0.62–0.86, sensitivity 0.63, specificity 0.75). (D) The ROC curve for discriminating patients with AIS from healthy controls via lncRNA-AC136007.2 had offered the greater diagnostic ability with an AUC of 0.94 (95% CI, 0.88–0.99, sensitivity 90.63, specificity 90.63). The measured RNA expression levels were normalized by GAPDH (*P < 0.05, **P < 0.001).